• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Dilated cardiomyopathy is conventionally defined as the presence of left ventricular or
biventricular dilatation or systolic dysfunction in the absence of abnormal loading conditions …

Dilated cardiomyopathy (DCM) is a complex disease with multiple causes and various
pathogenic mechanisms. Despite improvements in the prognosis of patients with DCM in the …

In the modern era, cardiologists managing patients and families with cardiomyopathies need
to be familiar with every stage of the diagnostic pathway from clinical phenotyping to the …

Cardiomyopathies represent significant contributors to cardiovascular morbidity and
mortality. Over the past decades, a progress has occurred in characterization of the genetic …

Abstract Background and Aims Pathogenic variants in the desmoplakin (DSP) gene are
associated with the development of a distinct arrhythmogenic cardiomyopathy phenotype …

Dilated cardiomyopathy (DCM) represents one of the most common causes of non-ischemic
heart failure, characterised by ventricular dilation alongside systolic dysfunction. Despite …

Dilated cardiomyopathy (DCM) is extensively discussed in numerous expert consensus
documents and international guidelines, with differing recommendations. To support …

Considering the worldwide impact of heart failure, it is crucial to develop approaches that
can help us comprehend its root cause and make accurate predictions about its outcome …

Dilated cardiomyopathy (DCM) is a common cause of heart failure and is the primary
indication for heart transplantation. A genetic etiology can be found in 20-35% of patients …